Enveric Biosciences Inc (ENVB)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
No company overview is available for Enveric Biosciences Inc yet.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Enveric Biosciences completes private placement, raising up to $5 million
# 📜 What This Document Is 📰 This document is a highly technical piece of legal paperwork, specifically an exhibit to an 8-K (Current Report) filing. Essentially, it is a **Securities Purchase Agreement**. This agreement governs a large "private placement," which means the company (Enveric Bioscie
March 2026
Enveric Biosciences, Inc. — 8-K Filing
# 🧾 What This Document Is This is a current report on Form 8-K, which companies file with the SEC to announce major events. Attached is a press release (Exhibit 99.1) detailing Enveric's financial results for 2025 and a major corporate update. Think of it as the company's "year-in-review" and "here
SEC filings
All filings →Insider trades
All insider trades →Enveric Biosciences Inc has no reported insider trades in the last 90 days.